We are live on ! Find out more
EPM

Equitec Proprietary Markets Portfolio holdings

AUM $559M
1-Year Est. Return 230.29%
This Fund
S&P 500
This Quarter Est. Return
+23.9%
1 Year Est. Return
+230.29%
3 Year Est. Return
+526.89%
5 Year Est. Return
+679.16%
10 Year Est. Return
–
AUM
$106M
AUM Growth
-$34.7M
Cap. Flow
-$44.6M
Cap. Flow %
-42.09%
Top 10 Hldgs %
87.06%
Holding
85
New
19
Increased
12
Reduced
9
Closed
20

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$9.61M
2
K
Kellanova
K
+$4.37M
3
KBDC
Kayne Anderson BDC
KBDC
+$642K
4
SAGE
Sage Therapeutics
SAGE
+$470K
5
JNPR
Juniper Networks
JNPR
+$233K

Top Sells

Rank Stock Value
1
X
US Steel
X
+$10.1M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$8.57M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$7.27M
4
AMED
Amedisys
AMED
+$1.61M
5
BLUE
bluebird bio
BLUE
+$540K

Sector Composition

Rank Sector Weight
1 Healthcare 12.37%
2 Consumer Staples 6.77%
3 Financials 1.97%
4 Industrials 1.08%
5 Utilities 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
76
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
– –
-5,000
Closed -$2.8M
X
77
CALL
DELISTED
US Steel
X
– –
-154,300
Closed -$6.52M
X
78
DELISTED
US Steel
X
– –
-239,800
Closed -$10.1M
X
79
PUT
DELISTED
US Steel
X
– –
-319,400
Closed -$13.5M
DMN
80
DELISTED
Damon Inc. Common Stock
DMN
– –
-30
Closed –
CMRX
81
CALL
DELISTED
Chimerix, Inc.
CMRX
– –
-2,500
Closed -$21.3K
PDCO
82
CALL
DELISTED
Patterson Companies, Inc.
PDCO
– –
-6,000
Closed -$187K
ITCI
83
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-28,800
Closed -$3.8M
ITCI
84
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-55,100
Closed -$7.27M
ITCI
85
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-115,200
Closed -$15.2M
1 2 3
4

Similar funds

DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
HA
Harfst & Associates Sheridan, Wyoming $560M AUM 17.69% 1-Year Est. Return
OPWM
Oakwell Private Wealth Management Austin, Texas $560M AUM 20.18% 1-Year Est. Return
MP
Moment Partners San Francisco, California $561M AUM 16.01% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $558M AUM 14.72% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Equitec Proprietary Markets's Q2 2025 Portfolio in Review

As of Q2 2025, Equitec Proprietary Markets held 85 positions worth $106M, down 25% from $141M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Equitec Proprietary Markets withdrew a net $44.6M in Q2 2025, closing 20 positions and reducing 9 holdings. Its most notable exit was US Steel, an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 7% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Equitec Proprietary Markets opened a new position in Blueprint Medicines worth $11.9M.

  • Equitec Proprietary Markets's largest Q2 2025 buy was Blueprint Medicines: 92,500 shares worth $11.9M.
  • Equitec Proprietary Markets added most to Kellanova in Q2 2025, an estimated $4.37M increase.
  • Equitec Proprietary Markets's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $8.57M.
  • Equitec Proprietary Markets fully exited US Steel in Q2 2025, selling an estimated $10.1M.
  • Equitec Proprietary Markets's ten largest holdings make up 87% of its $106M portfolio in Q2 2025.
  • Equitec Proprietary Markets opened 19 new positions and closed 20 in Q2 2025.
  • Equitec Proprietary Markets's portfolio value fell 25% quarter-over-quarter to $106M.

Based on Equitec Proprietary Markets's 13F filing for Q2 2025, filed 6 Aug 2025.